Cargando…

Molecular switches regulating the potency and immune evasiveness of SARS-CoV-2 spike protein

SARS-CoV-2 spike protein plays a key role in viral entry and host immune responses. The conformation of the spike protein can be either open or closed, yet it is unclear how the conformations affect the protein’s functions or what regulate the conformational changes. Using SARS-CoV-1 and bat RaTG13-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Yushun, Huang, Linfen, Zhang, Xiujuan, Shang, Jian, Perlman, Stanley, Du, Lanying, Li, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491847/ https://www.ncbi.nlm.nih.gov/pubmed/34611654 http://dx.doi.org/10.21203/rs.3.rs-736159/v2

Ejemplares similares

Lys417 acts as a molecular switch that regulates the conformation of SARS-CoV-2 spike protein
por: Geng, Qibin, et al.
Publicado: (2023)

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates
por: Ye, Gang, et al.
Publicado: (2021)

Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern
por: Shi, Juan, et al.
Publicado: (2022)

RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge
por: Shi, Juan, et al.
Publicado: (2022)

The Development of a Novel Nanobody Therapeutic for SARS-CoV-2
por: Ye, Gang, et al.
Publicado: (2020)

Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants
por: Ghimire, Dibya, et al.
Publicado: (2022)

MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection
por: Tai, Wanbo, et al.
Publicado: (2023)

The spike protein of SARS-CoV — a target for vaccine and therapeutic development
por: Du, Lanying, et al.
Publicado: (2009)

Evasion by Stealth: Inefficient Immune Activation Underlies Poor T Cell Response and Severe Disease in SARS-CoV-Infected Mice
por: Zhao, Jincun, et al.
Publicado: (2009)

SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies
por: Yang, Yang, et al.
Publicado: (2021)

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion
por: Jimenez Ruiz, Jose A., et al.
Publicado: (2022)

Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion
por: Salleh, Mohd Zulkifli, et al.
Publicado: (2021)

Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis
por: Baldari, Cosima T., et al.
Publicado: (2023)

Cell entry mechanisms of SARS-CoV-2
por: Shang, Jian, et al.
Publicado: (2020)

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

mRNA vaccines elicit potent neutralization against multiple SARS-CoV-2 omicron subvariants and other variants of concern
por: Wang, Gang, et al.
Publicado: (2022)

Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2021)

Immunity evasion: consequence of the N501Y mutation of the SARS-CoV-2 spike glycoprotein
por: Uzoeto, Henrietta Onyinye, et al.
Publicado: (2022)

Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge
por: Guan, Xiaoqing, et al.
Publicado: (2023)

A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection
por: Shi, Juan, et al.
Publicado: (2022)

Selection of and evasion from cytotoxic T cell responses in the central nervous system
por: Perlman, Stanley, et al.
Publicado: (2001)

Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
por: Du, Lanying, et al.
Publicado: (2007)

Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
por: Chen, Shiqi, et al.
Publicado: (2023)

Structural basis of receptor recognition by SARS-CoV-2
por: Shang, Jian, et al.
Publicado: (2020)

Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
por: Sun, Cong, et al.
Publicado: (2022)

Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
por: Wan, Yushun, et al.
Publicado: (2020)

Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains
por: Qing, Enya, et al.
Publicado: (2021)

Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC
por: Du, Lanying, et al.
Publicado: (2013)

Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: Revealing the critical antigenic determinants in inactivated SARS-CoV vaccine
por: He, Yuxian, et al.
Publicado: (2006)

Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic Interventions
por: Shah, Masaud, et al.
Publicado: (2021)

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex
por: Mannar, Dhiraj, et al.
Publicado: (2022)

Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry
por: Qing, Enya, et al.
Publicado: (2022)

Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients
por: Cao, Zhiliang, et al.
Publicado: (2010)

Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection
por: Geng, Qibin, et al.
Publicado: (2021)

Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction
por: Cao, Wenpeng, et al.
Publicado: (2021)

A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency
por: Leach, Adam, et al.
Publicado: (2021)

Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry
por: Shang, Jian, et al.
Publicado: (2020)

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus
por: Wan, Yushun, et al.
Publicado: (2020)

Antibody evasion properties of SARS-CoV-2 Omicron sublineages
por: Iketani, Sho, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4nmctk09b99fv19ajr2jes25c7